サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
表紙：ユーバイオティクスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年予測
市場調査レポート
商品コード
1305213

ユーバイオティクスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年予測

Global Eubiotics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日
ページ情報
英文 230 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ユーバイオティクスの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年予測
出版日: 2023年06月01日
発行: Value Market Research
ページ情報: 英文 230 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ユーバイオティクスの世界需要は、2022年の81億2,000万米ドルから、2023年～2030年の調査期間中にCAGR 8.55%で2030年には169億9,000万米ドル近くの市場規模に達すると推定されます。

ユーバイオティクスとは、動物の消化器系における微生物のバランスと健康を促進する物質や技術を表す用語です。動物の健康と成績を向上させるために、プロバイオティクス、プレバイオティクス、有機酸、酵素などの飼料添加物を使用することを指します。ユーバイオティクスは畜産において、飼料中の抗生物質やその他の化学添加物の使用を減らすために使用されます。また、動物の健康、福祉、生産性を向上させ、病気の発生率や獣医介入の必要性を減らすためにも使用されます。

市場力学：

世界の食肉・畜産物需要の拡大が、飼料用ユーバイオティクスの需要を牽引しています。ユーバイオティクスは動物の健康と生産性の向上に役立ち、肉や乳製品の質と量の向上につながります。多くの国で動物飼料における抗生物質成長促進剤の使用が制限されているため、動物の健康と成績を向上させる天然の代替品としてユーバイオティクスの使用が増加しています。動物飼料における抗生物質の使用と、それが動物の健康と福祉に及ぼす潜在的な影響に対する消費者と動物愛護団体の意識の高まりが、ユーバイオティクスの需要を牽引しています。食品の安全性と品質に対する懸念の高まりが、動物飼料におけるユーバイオティクスの需要を促進しています。ユーバイオティクスは抗生物質の安全で自然な代替品と考えられており、その使用により食肉や動物製品の品質と安全性を向上させることができます。マイクロカプセル化やナノテクノロジーなど、ユーバイオティクスの生産における新しく高度な技術の開拓が、ユーバイオティクス市場の成長を促進しています。経済成長を続ける中国、インド、ブラジルにおける食肉・畜産物需要の高まりが、動物飼料におけるユービオティクスの需要を牽引しています。これらの地域からの需要の増加は、今後数年間、世界のユービオティクス市場の成長を促進すると予想されます。

本レポートでは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界構造を明確に把握し、競合の魅力を世界レベルで評価するのに役立ちます。さらに、これらのツールは、ユーバイオティクスの世界市場における各セグメントを包括的に評価することもできます。ユーバイオティクス産業の成長と動向は、この調査に総合的なアプローチを提供します。

市場セグメンテーション：

ユーバイオティクス市場レポートのこのセクションでは、国別および地域別にセグメントを分析することにより、セグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスのターゲット層と今後の機会を特定するのに役立ちます。

タイプ別

  • プロバイオティクス
  • プレバイオティクス
  • エッセンシャルオイル
  • 有機酸

形態別

  • 固体
  • 液体

家畜別

  • 家禽
  • 豚
  • 反芻動物
  • 水生動物

機能別

  • 栄養と腸の健康
  • 生産高
  • 免疫
  • 生産

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおけるユーバイオティクス市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 ユーバイオティクス-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 ユーバイオティクスの世界市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • プロバイオティクス
  • プレバイオティクス
  • エッセンシャルオイル
  • 有機酸

第7章 ユーバイオティクスの世界市場分析：形態別

  • 形態別概要
  • 実績データと予測データ
  • 形態別分析
  • 固体
  • 液体

第8章 ユーバイオティクスの世界市場分析：家畜別

  • 家畜別概要
  • 実績データと予測データ
  • 家畜別分析
  • 家禽
  • 豚
  • 反芻動物
  • 水生動物

第9章 ユーバイオティクスの世界市場分析：機能別

  • 機能別概要
  • 実績データと予測データ
  • 機能別分析
  • 栄養と腸の健康
  • 収穫
  • 免疫
  • 生産

第10章 ユーバイオティクスの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第11章 ユーバイオティクス企業の競合情勢

  • ユーバイオティクス市場競合
  • 提携・協力・協定
  • 合併・買収
  • 新製品発売
  • その他の開発

第12章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • DSM
  • Novozymes
  • Kemin Industries Inc.
  • Roquette Freres
  • FrieslandCampina
  • Neospark Drugs and Chemicals Private Limited
  • ASAHI GROUP HOLDINGS Ltd.
  • Lesaffre
  • MSPrebiotics Inc.
  • ADM
  • Lallemand Inc.
  • BEHN MEYER
  • NOVUS INTERNATIONAL
  • BENEO
  • Yara
  • Cargill Incorporated
  • BASF SE
  • Chr. Hansen Holding A/S
  • ADDCON GmbH

注-企業プロファイルにおいて、財務の詳細や最近の動向は、非公開会社の場合、入手可能であるか、またはカバーされていない可能性があります。

図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (Units and USD MN)
  • Probiotics Market Sales by Geography (Units and USD MN)
  • Prebiotics Market Sales by Geography (Units and USD MN)
  • Essential Oils Market Sales by Geography (Units and USD MN)
  • Organic Acids Market Sales by Geography (Units and USD MN)
  • Analysis Market by Form (Units and USD MN)
  • Solid Market Sales by Geography (Units and USD MN)
  • Liquid Market Sales by Geography (Units and USD MN)
  • Analysis by Livestock (Units and USD MN)
  • Poultry Market Sales by Geography (Units and USD MN)
  • Swine Market Sales by Geography (Units and USD MN)
  • Ruminants Market Sales by Geography (Units and USD MN)
  • Aquatic Animals Market Sales by Geography (Units and USD MN)
  • Analysis by Function (Units and USD MN)
  • Nutrition & Gut Health Market Sales by Geography (Units and USD MN)
  • Yield Market Sales by Geography (Units and USD MN)
  • Immunity Market Sales by Geography (Units and USD MN)
  • Production Market Sales by Geography (Units and USD MN)
  • Global Eubiotics Market Sales by Geography (Units and USD MN)
  • North America Market Analysis (Units and USD MN)
  • United State Market Analysis (Units and USD MN)
  • Canada Market Analysis (Units and USD MN)
  • Mexico Market Analysis (Units and USD MN)
  • Europe Market Analysis (Units and USD MN)
  • Europe Market Estimate by Country (Units and USD MN)
  • United Kingdom Market Analysis (Units and USD MN)
  • France Market Analysis (Units and USD MN)
  • Germany Market Analysis (Units and USD MN)
  • Italy Market Analysis (Units and USD MN)
  • Russia Market Analysis (Units and USD MN)
  • Spain Market Analysis (Units and USD MN)
  • Rest of Europe Market Analysis (Units and USD MN)
  • Asia Pacific Market Analysis (Units and USD MN)
  • China Market Analysis (Units and USD MN)
  • Japan Market Analysis (Units and USD MN)
  • India Market Analysis (Units and USD MN)
  • South Korea Market Analysis (Units and USD MN)
  • Australia Market Analysis (Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Units and USD MN)
  • Latin America Market Analysis (Units and USD MN)
  • Brazil Market Analysis (Units and USD MN)
  • Argentina Market Analysis (Units and USD MN)
  • Peru Market Analysis (Units and USD MN)
  • Chile Market Analysis (Units and USD MN)
  • Rest of Latin America Market Analysis (Units and USD MN)
  • Middle East & Africa Market Analysis (Units and USD MN)
  • Saudi Arabia Market Analysis (Units and USD MN)
  • UAE Market Analysis (Units and USD MN)
  • Israel Market Analysis (Units and USD MN)
  • South Africa Market Analysis (Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Eubiotics Report
  • Market Research Process
  • Market Research Methodology
  • Global Eubiotics Market Size, by Region (Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Form
  • Market Attractiveness Analysis by Livestock
  • Market Attractiveness Analysis by Function
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (Units and USD MN)
  • Probiotics Market Sales by Geography (Units and USD MN)
  • Prebiotics Market Sales by Geography (Units and USD MN)
  • Essential Oils Market Sales by Geography (Units and USD MN)
  • Organic Acids Market Sales by Geography (Units and USD MN)
  • Global Market Analysis by Form (Units and USD MN)
  • Solid Market Sales by Geography (Units and USD MN)
  • Liquid Market Sales by Geography (Units and USD MN)
  • Global Market Analysis by Livestock (Units and USD MN)
  • Poultry Market Sales by Geography (Units and USD MN)
  • Swine Market Sales by Geography (Units and USD MN)
  • Ruminants Market Sales by Geography (Units and USD MN)
  • Aquatic Animals Market Sales by Geography (Units and USD MN)
  • Global Market Analysis by Function (Units and USD MN)
  • Nutrition & Gut Health Market Sales by Geography (Units and USD MN)
  • Yield Market Sales by Geography (Units and USD MN)
  • Immunity Market Sales by Geography (Units and USD MN)
  • Production Market Sales by Geography (Units and USD MN)
  • Global Market Sales (Units and USD MN)
  • North America Market Sales (Units and USD MN)
  • Europe Market Sales (Units and USD MN)
  • Asia Pacific Market Sales (Units and USD MN)
  • Latin America Market Sales (Units and USD MN)
  • Middle East & Africa Market Sales (Units and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112110645

The global demand for Eubiotics Market is presumed to reach the market size of nearly USD 16.99 BN by 2030 from USD 8.12 BN in 2022 with a CAGR of 8.55% under the study period of 2023 - 2030. Regarding volume, the market was calculated XX Units in 2022 and forecast to touch XX Units by 2030 with a CAGR of XX% during 2023 - 2030.

Eubiotics is a term used to describe substances or techniques that promote the balance and well-being of microorganisms in the digestive system of animals. It refers to the use of feed additives, such as probiotics, prebiotics, organic acids, and enzymes, to improve the health and performance of animals. Eubiotics are used in animal husbandry to reduce the use of antibiotics and other chemical additives in feed, as they provide a natural and safe alternative. They are also used to improve animal health, welfare, and productivity, as well as to reduce the incidence of diseases and the need for veterinary interventions.

Market Dynamics:

The growing demand for meat and animal products worldwide is driving the demand for eubiotics in animal feed. Eubiotics help improve animal health and productivity, which leads to better quality and quantity of meat and dairy products. The restriction on antibiotic growth promoters' usage in animal feed in many countries has led to the increased use of eubiotics as a natural alternative to improve animal health and performance. The increasing awareness among consumers and animal welfare organizations about the use of antibiotics in animal feed and its potential impact on animal health and welfare are driving the demand for eubiotics. The rising concerns about food safety and quality are driving the demand for eubiotics in animal feed. Eubiotics are considered safe and natural alternatives to antibiotics, and their use can improve the quality and safety of meat and animal products. The development of new and advanced technologies in the production of eubiotics, such as microencapsulation and nanotechnology, is driving the growth of the eubiotics market. The rising demand for meat and animal products in the growing economies of China, India, and Brazil is driving the demand for eubiotics in animal feed. The increasing demand from these regions is expected to drive the growth of the global eubiotics market in the coming years.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of eubiotics. The growth and trends of Eubiotics Industry provide a holistic approach to this study.

Market Segmentation:

This section of the eubiotics market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Probiotics
  • Prebiotics
  • Essential Oils
  • Organic Acids

By Form

  • Solid
  • Liquid

By Livestock

  • Poultry
  • Swine
  • Ruminants
  • Aquatic Animals

By Function

  • Nutrition & Gut Health
  • Yield
  • Immunity
  • Production

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Eubiotics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the eubiotics market include DSM, Novozymes, Kemin Industries Inc., Roquette Freres, FrieslandCampina, Neospark Drugs and Chemicals Private Limited, ASAHI GROUP HOLDINGS Ltd., Lesaffre, MSPrebiotics Inc., ADM, Lallemand Inc., BEHN MEYER, NOVUS INTERNATIONAL, BENEO, Yara, Cargill Incorporated, BASF SE, Chr. Hansen Holding A/S, ADDCON GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . EUBIOTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Form
    • 3.7.3 Market Attractiveness Analysis By Livestock
    • 3.7.4 Market Attractiveness Analysis By Function
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL EUBIOTICS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Probiotics Historic and Forecast Sales by Regions
  • 6.5 Prebiotics Historic and Forecast Sales by Regions
  • 6.6 Essential Oils Historic and Forecast Sales by Regions
  • 6.7 Organic Acids Historic and Forecast Sales by Regions

7 . GLOBAL EUBIOTICS MARKET ANALYSIS BY FORM

  • 7.1 Overview by Form
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Form
  • 7.4 Solid Historic and Forecast Sales by Regions
  • 7.5 Liquid Historic and Forecast Sales by Regions

8 . GLOBAL EUBIOTICS MARKET ANALYSIS BY LIVESTOCK

  • 8.1 Overview by Livestock
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Livestock
  • 8.4 Poultry Historic and Forecast Sales by Regions
  • 8.5 Swine Historic and Forecast Sales by Regions
  • 8.6 Ruminants Historic and Forecast Sales by Regions
  • 8.7 Aquatic Animals Historic and Forecast Sales by Regions

9 . GLOBAL EUBIOTICS MARKET ANALYSIS BY FUNCTION

  • 9.1 Overview by Function
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Function
  • 9.4 Nutrition & Gut Health Historic and Forecast Sales by Regions
  • 9.5 Yield Historic and Forecast Sales by Regions
  • 9.6 Immunity Historic and Forecast Sales by Regions
  • 9.7 Production Historic and Forecast Sales by Regions

10 . GLOBAL EUBIOTICS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE EUBIOTICS COMPANIES

  • 11.1. Eubiotics Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF EUBIOTICS INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. DSM
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Novozymes
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Kemin Industries Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Roquette Freres
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. FrieslandCampina
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Neospark Drugs and Chemicals Private Limited
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. ASAHI GROUP HOLDINGS Ltd.
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Lesaffre
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. MSPrebiotics Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. ADM
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Lallemand Inc.
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. BEHN MEYER
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. NOVUS INTERNATIONAL
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. BENEO
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. Yara
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. Cargill Incorporated
    • 12.18.1. Company Overview
    • 12.18.2. Company Revenue
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. BASF SE
    • 12.19.1. Company Overview
    • 12.19.2. Company Revenue
    • 12.19.3. Products
    • 12.19.4. Recent Developments
  • 12.20. Chr. Hansen Holding A/S
    • 12.20.1. Company Overview
    • 12.20.2. Company Revenue
    • 12.20.3. Products
    • 12.20.4. Recent Developments
  • 12.21. ADDCON GmbH
    • 12.21.1. Company Overview
    • 12.21.2. Company Revenue
    • 12.21.3. Products
    • 12.21.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies